- NCIt
- C27949
Loading cancer entity…
Loading cancer entity…
Clinical trials
27 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03240679 | Endoscopic Mucosal Resection and Cellular Matrix | terminated | N/A | 3 | Mayo ClinicOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT00064259 | A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer | terminated | Phase 1 / Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 17, 2021 | clinicaltrials |
| NCT04549584 |
| Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer(NEO-SMART) |
| terminated |
| — |
| 3 |
| Seoul National University HospitalOTHER |
| 1 |
| Dec 17, 2020 |
| clinicaltrials |
Data updated 23 days agoSource updated Feb 6, 2023source: clinicaltrials